Editorial Board for section 'Thoracic Oncology'
- Bone and Soft Tissue Oncology Section
- Breast Cancer Section
- Cell Therapy Section
- Childhood, Adolescent and Young Adult Oncology Section
- Dermato-Oncology Section
- Gastrointestinal Oncology Section
- Genitourinary Oncology Section
- Gynecologic Oncology Section
- Head and Neck Oncology Section
- Health Economics Section
- Hematology Section
- Neuro-Oncology Section
- Oncology Biomarkers Section
- Oncology Nursing Section
- Palliative and Supportive Care Section
- Psychosocial Oncology Section
- Surgical Oncology Section
- Thoracic Oncology Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Centre Hospitalier de L'Universite de Montreal, Montreal, QC, Canada
Interests: thoracic malignancies; urologic malignancies; bladder cancer
* Section: Thoracic Oncology
Interests: thoracic malignancies; urologic malignancies; bladder cancer
* Section: Thoracic Oncology
Division of Medical Oncology, Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada
Interests: thoracic malignancies; phase I trials
Interests: thoracic malignancies; phase I trials
Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada
Interests: thoracic malignancies; COPD; immunotherapy; screening
Interests: thoracic malignancies; COPD; immunotherapy; screening
Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
Interests: thoracic cancer; lung cancer; chemotherapy; immune-checkpoint inhibitor; molecular targeted drugs
Interests: thoracic cancer; lung cancer; chemotherapy; immune-checkpoint inhibitor; molecular targeted drugs
Department of Breast Oncology, Aichi Cancer Center, Chikusa-ku, Nagoya, Aichi 464-8681, Japan
Interests: breast cancer; surgery; develpment of new agents; clinical trial in breast cancer
Interests: breast cancer; surgery; develpment of new agents; clinical trial in breast cancer
Dr. Toshiyuki Kozuki
Section Board Member
National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
Interests: lung cancer; malignant mesothelioma; chemotherapy; clinical trial
Interests: lung cancer; malignant mesothelioma; chemotherapy; clinical trial
Department of Oncology, Università degli Studi di Torino, Turin, Italy
Interests: thoracic oncology; thoracic surgery; oncology
Interests: thoracic oncology; thoracic surgery; oncology
Faculty of Health Sciences, Hull York Medical School, York YO10 5DD, UK
Interests: oncogeriatrics; thoracic oncology; mesothelioma
Special Issues, Collections and Topics in MDPI journals
Interests: oncogeriatrics; thoracic oncology; mesothelioma
Special Issues, Collections and Topics in MDPI journals
Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada
Interests: lung cancer; kidney cancer; oligometastases; stereotactic radiotherapy; health economics
Interests: lung cancer; kidney cancer; oligometastases; stereotactic radiotherapy; health economics
1. Department of General Surgery and Medical Specialties, Minimally Invasive Thoracic Surgery and New Technology, Policlinic University Hospital, University of Catania, Catania, Italy
2. Thoracic Surgery & Lung Transplant, Lung Health Centre, Organ Transplant Center of Excellence (OTCoE), King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Interests: thoracic surgery; VATS; uniportal VATS; surgical innovation; hyperthermic intrathoracic chemotherapy; malignant pleural mesothelioma; lung metastases; advanced lung cancer; esophageal surgery
2. Thoracic Surgery & Lung Transplant, Lung Health Centre, Organ Transplant Center of Excellence (OTCoE), King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Interests: thoracic surgery; VATS; uniportal VATS; surgical innovation; hyperthermic intrathoracic chemotherapy; malignant pleural mesothelioma; lung metastases; advanced lung cancer; esophageal surgery
Dr. Kirstin Perdrizet
Section Board Member
Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada
Interests: thoracic oncology; biomarkers; targeted therapy; lung; thymic; esophagogastric cancers; epidemiology; statistical modeling
Interests: thoracic oncology; biomarkers; targeted therapy; lung; thymic; esophagogastric cancers; epidemiology; statistical modeling
